Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Soliton Inc (SOLY)

Soliton Inc (SOLY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 140,705
  • Shares Outstanding, K 16,932
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,750 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 14.50

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.64 +25.15%
on 03/20/20
12.50 -33.52%
on 03/04/20
-2.39 (-22.34%)
since 02/27/20
3-Month
6.64 +25.15%
on 03/20/20
15.30 -45.69%
on 01/23/20
-2.72 (-24.66%)
since 12/27/19
52-Week
5.01 +65.70%
on 05/23/19
29.00 -71.34%
on 05/29/19
+1.58 (+23.48%)
since 03/27/19

Most Recent Stories

More News
Soliton to Present Pivotal Cellulite Clinical Trial Results at Virtual AAD 2020 Annual Meeting

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 8.31 (-5.57%)
Lead Investigator Evaluates Next-Step for Soliton Pivotal Cellulite Clinical Data

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 8.31 (-5.57%)
Soliton Receives FDA Clearance of Special 510(k)

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 8.31 (-5.57%)
Soliton signs Agreement with Global Manufacturer Sanmina

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SANM : 25.32 (-9.08%)
SOLY : 8.31 (-5.57%)
Soliton to Present Pivotal Cellulite Clinical Trial Results at AAD on March 21, 2020

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 8.31 (-5.57%)
Soliton Reports Fourth Quarter and Full Year 2019 Results

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 8.31 (-5.57%)
Global Medical Device Industry Bolstering Outstanding Growth Potentials

There is no doubt that the global medical device market has been showing outstanding growth for the last few years and that it will continue to do so in the near future... and most likely beyond then....

SOLY : 8.31 (-5.57%)
MDT : 89.89 (-2.23%)
IVC : 7.20 (+5.88%)
RMTI : 2.19 (-10.61%)
ABT : 74.56 (-1.65%)
Soliton Files Special 510(k) with FDA for its Generation II RAP Device

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 8.31 (-5.57%)
Soliton Advances Market Launch Preparation; Appoints James Bucher as Senior Sales Consultant

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 8.31 (-5.57%)
Soliton Announces Positive Data from Extended Keloid and Hypertrophic Scar Trials

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 8.31 (-5.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade SOLY with:

Business Summary

Soliton Inc. is a medical device company. Its commercial product uses rapid pulses of designed acoustic shockwaves to dramatically accelerate the removal of unwanted tattoos. Soliton Inc. is based in Houston, Texas.

See More

Key Turning Points

2nd Resistance Point 8.98
1st Resistance Point 8.65
Last Price 8.31
1st Support Level 8.03
2nd Support Level 7.74

See More

52-Week High 29.00
Fibonacci 61.8% 19.84
Fibonacci 50% 17.01
Fibonacci 38.2% 14.18
Last Price 8.31
52-Week Low 5.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar